CIK 0001041024
- Non-accelerated filer
- Smaller reporting company
ROCKWELL MEDICAL, INC.
Sign in to watch- Ticker
- RMTI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383317208
- Phone
- +1 800-449-3353
- Business address
- 30142 WIXOM ROAD, WIXOM, MI, 48393
- Former names
- ROCKWELL MEDICAL TECHNOLOGIES INC
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award SVP, Chief Commercial Officer acquired 85,000 shares (grant or award)
- 4 Grant or award SVP, FINANCE AND CFO acquired 97,500 shares (grant or award)
- 4 Grant or award EVP, CLO and Secretary acquired 97,500 shares (grant or award)
- 4 Grant or award President and CEO acquired 220,000 shares (grant or award)
- 4 Open-market buy 10% owner bought 87,500 shares at an average $1.07 ($94,018)
- 4 Planned sale President and CEO sold 6,926 shares at $1.08 ($7,480)
- 4 Planned sale SVP, FINANCE AND CFO sold 886 shares at $1.10 ($975)
- 4 Planned sale SVP, Chief Commercial Officer sold 2,868 shares at $1.08 ($3,097)
- 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 5,267 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, FINANCE AND CFO gave up 2,444 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CLO and Secretary gave up 6,803 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 13,434 shares (to pay taxes)
- 4 Planned sale SVP, Chief Commercial Officer sold 1,001 shares at $2.05 ($2,052)
- 4 Planned sale President and CEO sold 2,163 shares at $2.06 ($4,445)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 29,991 shares at an average $2.35 ($70,379)
- 4 Planned sale SVP, Chief Commercial Officer sold 1,001 shares at $3.69 ($3,689)
- 4 Planned sale President and CEO sold 2,163 shares at $3.69 ($7,971)
Page 3 of 24 · 470 filings